Publikation: A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity
Dateien
Datum
Autor:innen
Herausgeber:innen
ISSN der Zeitschrift
Electronic ISSN
ISBN
Bibliografische Daten
Verlag
Schriftenreihe
Auflagebezeichnung
URI (zitierfähiger Link)
DOI (zitierfähiger Link)
Internationale Patentnummer
Angaben zur Forschungsförderung
Projekt
Open Access-Veröffentlichung
Sammlungen
Core Facility der Universität Konstanz
Titel in einer weiteren Sprache
Publikationstyp
Publikationsstatus
Erschienen in
Zusammenfassung
Vaccination with oncogene-derived DNA for anti-cancer treatment carries a risk of de-novo tumor induction triggered by the persisting recombinant DNA. We hypothesized that an oncoprotein whose primary sequence has been rearranged (‘shuffled’) to maintain all possible T cell epitopes still induces cytotoxic T cells against the authentic protein but is devoid of transforming properties. As a model antigen, we used the E7 oncoprotein of the human papillomavirus (HPV) type 16, the major cause of cervical cancer. We have generated an artificial E7 molecule in which four domains were rearranged and, in order to maintain all possible T cell epitopes, certain sequences were duplicated. Upon transfection of this shuffled E7 gene (E7SH) into RMA cells, presentation of an E7 Db-restricted T cell epitope was shown by an E7-specific CTL line in vitro. Immunization of C57BL/6 mice with E7SH DNA induced E7-specific CTL and also conveyed protection against E7-positive syngeneic tumor cells. No transforming activity of E7SH DNA in NIH3T3 cells was detected, as determined by focus formation, induction of S-phase under conditions of serum deprivation and degradation of endogenous pRB. Our results suggest that DNA shuffling may become a promising concept for DNA-based anti-cancer vaccines.
Zusammenfassung in einer weiteren Sprache
Fachgebiet (DDC)
Schlagwörter
Konferenz
Rezension
Zitieren
ISO 690
OSEN, Wolfram, Tanja PEILER, Peter ÖHLSCHLÄGER, Sandra CALDEIRA, Stefan FAATH, Nico MICHEL, Martin MÜLLER, Massimo TOMMASINO, Ingrid JOCHMUS, Lutz GISSMANN, 2001. A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity. In: Vaccine. 2001, 19(30), pp. 4276-4286. ISSN 0264-410X. Available under: doi: 10.1016/S0264-410X(01)00154-2BibTex
@article{Osen2001vacci-17500, year={2001}, doi={10.1016/S0264-410X(01)00154-2}, title={A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity}, number={30}, volume={19}, issn={0264-410X}, journal={Vaccine}, pages={4276--4286}, author={Osen, Wolfram and Peiler, Tanja and Öhlschläger, Peter and Caldeira, Sandra and Faath, Stefan and Michel, Nico and Müller, Martin and Tommasino, Massimo and Jochmus, Ingrid and Gissmann, Lutz} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/17500"> <dc:creator>Osen, Wolfram</dc:creator> <dc:creator>Peiler, Tanja</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dc:creator>Caldeira, Sandra</dc:creator> <dc:creator>Jochmus, Ingrid</dc:creator> <dc:creator>Tommasino, Massimo</dc:creator> <dc:contributor>Tommasino, Massimo</dc:contributor> <dc:contributor>Gissmann, Lutz</dc:contributor> <dc:contributor>Müller, Martin</dc:contributor> <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/> <dc:contributor>Jochmus, Ingrid</dc:contributor> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-13T08:27:29Z</dc:date> <dc:contributor>Michel, Nico</dc:contributor> <dcterms:bibliographicCitation>Publ. in: Vaccine ; 19 (2001), 30. - S. 4276-4286</dcterms:bibliographicCitation> <dc:creator>Michel, Nico</dc:creator> <dc:contributor>Caldeira, Sandra</dc:contributor> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:issued>2001</dcterms:issued> <dcterms:title>A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity</dcterms:title> <dc:creator>Öhlschläger, Peter</dc:creator> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/28"/> <dcterms:abstract xml:lang="eng">Vaccination with oncogene-derived DNA for anti-cancer treatment carries a risk of de-novo tumor induction triggered by the persisting recombinant DNA. We hypothesized that an oncoprotein whose primary sequence has been rearranged (‘shuffled’) to maintain all possible T cell epitopes still induces cytotoxic T cells against the authentic protein but is devoid of transforming properties. As a model antigen, we used the E7 oncoprotein of the human papillomavirus (HPV) type 16, the major cause of cervical cancer. We have generated an artificial E7 molecule in which four domains were rearranged and, in order to maintain all possible T cell epitopes, certain sequences were duplicated. Upon transfection of this shuffled E7 gene (E7SH) into RMA cells, presentation of an E7 Db-restricted T cell epitope was shown by an E7-specific CTL line in vitro. Immunization of C57BL/6 mice with E7SH DNA induced E7-specific CTL and also conveyed protection against E7-positive syngeneic tumor cells. No transforming activity of E7SH DNA in NIH3T3 cells was detected, as determined by focus formation, induction of S-phase under conditions of serum deprivation and degradation of endogenous pRB. Our results suggest that DNA shuffling may become a promising concept for DNA-based anti-cancer vaccines.</dcterms:abstract> <dc:rights>terms-of-use</dc:rights> <dc:contributor>Faath, Stefan</dc:contributor> <dc:creator>Müller, Martin</dc:creator> <dc:creator>Gissmann, Lutz</dc:creator> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/17500"/> <dc:contributor>Öhlschläger, Peter</dc:contributor> <dc:contributor>Peiler, Tanja</dc:contributor> <dc:language>eng</dc:language> <dc:contributor>Osen, Wolfram</dc:contributor> <dc:creator>Faath, Stefan</dc:creator> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-13T08:27:29Z</dcterms:available> </rdf:Description> </rdf:RDF>